Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rotavirus vaccines

G Barnes1

  • 1Department of Gastroenterology and Clinical Nutrition, Royal Children's Hospital, Parkville, Victoria, Melbourne, Australia.

Zhonghua Minguo Xiao Er Ke Yi Xue Hui Za Zhi [Journal]. Zhonghua Minguo Xiao Er Ke Yi Xue Hui
|April 29, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tislelizumab versus chemotherapy as second-line treatment for European and North American patients with advanced or metastatic esophageal squamous cell carcinoma: a subgroup analysis of the randomized phase III RATIONALE-302 study.

ESMO open·2023
Same author

Machine Learning Differentiation of Autism Spectrum Sub-Classifications.

Journal of autism and developmental disorders·2023
Same author

Tislelizumab versus chemotherapy as second-line treatment of advanced or metastatic esophageal squamous cell carcinoma (RATIONALE 302): impact on health-related quality of life.

ESMO open·2022
Same author

The effects of tislelizumab plus chemotherapy as first-line treatment on health-related quality of life of patients with advanced squamous non-small cell lung cancer: Results from a phase 3 randomized clinical trial.

Cancer treatment and research communications·2021
Same author

Patient acceptability and usability of a self-administered electronic patient-reported outcome assessment in HIV care: relationship with health behaviors and outcomes.

AIDS care·2020
Same author

A Fixed-point Scheme for the Numerical Construction of Magnetohydrostatic Atmospheres in Three Dimensions.

Solar physics·2018
Same journal

Group A streptococcal necrotizing fasciitis after varicella: report of two cases.

Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui·1999
Same journal

Harlequin ichthyosis: report of one case.

Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui·1999
Same journal

Severe combined immunodeficiency with B-lymphocytes (T-B+SCID): report of two cases.

Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui·1999
Same journal

Pemphigus vulgaris.

Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui·1999
Same journal

FISH analysis in both classical and atypical cases of Williams-Beuren syndrome.

Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui·1999
Same journal

Symptomatic hypomagnesemia in children.

Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui·1999
See all related articles

The tetravalent rhesus rotavirus vaccine shows 70-80% efficacy against severe rotavirus disease. This promising vaccine could soon be licensed, offering a vital strategy to combat a leading cause of child mortality worldwide.

Area of Science:

  • * Vaccinology and Pediatric Infectious Diseases
  • * Public Health and Preventative Medicine

Background:

  • * Rotavirus is a major cause of severe diarrheal disease and mortality in children globally.
  • * Significant progress has been made in developing effective rotavirus vaccines.

Purpose of the Study:

  • * To review the efficacy and potential impact of the tetravalent rhesus rotavirus vaccine.
  • * To discuss the landscape of current and emerging rotavirus vaccine candidates.
  • * To highlight key considerations for vaccine implementation and accessibility.

Main Methods:

  • * Review of data from large clinical trials of the tetravalent rhesus rotavirus vaccine.
  • * Analysis of recent study results from Venezuela and comparison with international trials.

Related Experiment Videos

  • * Discussion of ongoing research and development in rotavirus vaccine technology.

    • Main Results:

    • * The tetravalent rhesus rotavirus vaccine demonstrated 70-80% efficacy against severe rotavirus disease in major trials.
    • * Recent studies, including one from Venezuela, corroborate the efficacy observed in US and European trials.
    • * The vaccine is nearing potential licensure in the USA, presenting a significant public health opportunity.

    Conclusions:

    • * The tetravalent rhesus rotavirus vaccine represents a promising intervention against a leading childhood killer.
    • * Further research and policy advocacy are needed to address implementation challenges, including cost and global accessibility.
    • * Development of second and third-generation rotavirus vaccines is ongoing, expanding future prevention strategies.